Literature DB >> 19220556

Lung cancer patients in Queensland suffer delays in receiving radiation therapy--but not as a result of distance.

B H Burmeister1, D D Zarate, E A Burmeister, H E Harden, S P Colquist, D L Cossio, M G Poulsen, M Collins, G R Pratt, E T Walpole.   

Abstract

AIM: To determine whether lung cancer radiation therapy waiting times in Queensland public hospitals are associated with distance of residence from the nearest treatment facility.
METHODS: Retrospective analysis of radiation therapy waiting times of 1535 Queensland residents who were diagnosed with lung cancer from 2000 to 2004 and received radiation therapy as initial treatment at a public hospital. The effect of distance of residence from treatment centre on median waiting time was analysed by quantile regression controlling for sex, age, lung cancer histology, stage and therapeutic intent.
RESULTS: The median waiting time from diagnosis to start of radiation therapy was 33 days for all patients. There was no significant difference (P = 0.141) in median waiting times in relation to distance of residence from a treatment centre. However, in most patients, waiting times were significantly longer than recommended by the Royal Australian and New Zealand College of Radiologists. Curative patients waited longer than palliative patients, while patients with earlier stage cancer waited longer than those with more advanced disease.
CONCLUSION: Waiting times for radiation therapy among lung cancer patients in Queensland was not associated with distance from place of residence to the nearest public treatment facility. However, delays overall are excessive and are likely to worsen unless radiation treatment capabilities are enhanced to keep pace with population growth in Queensland.

Entities:  

Mesh:

Year:  2009        PMID: 19220556     DOI: 10.1111/j.1445-5994.2009.01912.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

Review 1.  Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.

Authors:  Christina Sinding; Rachel Warren; Donna Fitzpatrick-Lewis; Jonathan Sussman
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

2.  Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy--a comparison among prostate cancer patients treated in an Australian centre.

Authors:  Gerald B Fogarty; Diana Ng; Guilin Liu; Lauren E Haydu; Nastik Bhandari
Journal:  Radiat Oncol       Date:  2011-09-05       Impact factor: 3.481

Review 3.  Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review.

Authors:  Charlotte Kelly; Claire Hulme; Tracey Farragher; Graham Clarke
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

4.  The Psychosocial Influences of Waiting Periods on Patients Undergoing Endoscopic Submucosal Dissection.

Authors:  Noriko Nagao; Aya Tsuchiya; Sae Ando; Mizue Arita; Takashi Toyonaga; Ikuko Miyawaki
Journal:  Gastroenterol Nurs       Date:  2017 Sep/Oct       Impact factor: 0.978

5.  Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer - a register based cohort-study.

Authors:  Maria Iachina; Erik Jakobsen; Anne Kudsk Fallesen; Anders Green
Journal:  BMC Health Serv Res       Date:  2017-04-12       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.